Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Barclays analyst Benjamin Budish initiated coverage on Blue Owl Capital Inc. OWL with an Overweight rating and announced a price target of $29. Blue Owl Cap shares closed at $22.13 on Friday. See how other analysts view this stock.
- Citigroup analyst Thomas Palmer initiated coverage on Smithfield Foods, Inc. SFD with a Buy rating and announced a price target of $27. Smithfield Foods shares closed at $21.10 on Friday. See how other analysts view this stock.
- Leerink Partners analyst Mike Kratky initiated coverage on Beta Bionics, Inc. BBNX with an Outperform rating and announced a price target of $28. Beta Bionics shares closed at $20.57 on Friday. See how other analysts view this stock.
- Guggenheim analyst Michael Schmidt initiated coverage on Compass Therapeutics, Inc. CMPX with a Buy rating and announced a price target of $12. Compass Therapeutics shares closed at $2.92 on Friday. See how other analysts view this stock.
- LifeSci Capital analyst Jimmy Shan initiated coverage on Tourmaline Bio, Inc. TRML with an Outperform rating and announced a price target of $58. Tourmaline Bio shares closed at $12.21 on Friday. See how other analysts view this stock.
Considering buying SFD stock? Here’s what analysts think:
Trending Investment Opportunities
Advertisement
Read This Next:
Loading...
Loading...
BBNXBeta Bionics Inc
$14.463.40%
Edge Rankings
Momentum
N/A
Growth
N/A
Quality
N/A
Value
54.79
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|